F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman et al., Current protocols in molecular biology, 2000.

M. Bagdasarian, R. Lurz, B. Rückert, F. C. Franklin, M. M. Bagdasarian et al., Specific-purpose plasmid cloning vectors. II. Broad host range, high copy number, RSF1010-derived vectors and a host-vector system for gene cloning in Pseudomonas, Gene, vol.16, pp.237-247, 1981.

N. Bagge, M. Hentzer, J. B. Andersen, O. Ciofu, M. Givskov et al., Dynamic and spatial distribution of -lactamase expression in Pseudomonas aeruginosa biofilms, Antimicrob. Agents Chemother, vol.48, pp.1168-1174, 2004.

S. Ballestero, A. Fernández-rodríguez, R. Villaverde, H. Escobar, J. C. Pérez-díaz et al., Carbapenem resistance in Pseudomonas aeruginosa from cystic fibrosis patients, J. Antimicrob. Chemother, vol.38, pp.39-45, 1996.

L. Cao, R. Srikumar, and K. Poole, MexAB-OprM hyperexpression in NalC-type multidrug-resistant Pseudomonas aeruginosa: identification and characterization of the nalC gene encoding a repressor of PA3720-PA3719, Mol. Microbiol, vol.53, pp.1423-1436, 2004.

R. Chuanchuen, C. T. Narasaki, and H. P. Schweizer, The MexJK efflux pump of Pseudomonas aeruginosa requires OprM for antibiotic efflux but not for efflux of triclosan, J. Bacteriol, vol.184, pp.5036-5044, 2002.

, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, Approved standard, 2006.

, Performance standards for antimicrobial disk susceptibility tests. Approved standard, M2-A9, 2006.

D. M. Daigle, L. Cao, S. Fraud, M. S. Wilke, A. Pacey et al., Protein modulator of multidrug efflux gene expression in Pseudomonas aeruginosa, Antimicrob. Agents Chemother, vol.189, pp.5441-5451, 2007.

E. Drenkard, Antimicrobial resistance of Pseudomonas aeruginosa biofilms, Microbes Infect, vol.5, pp.1213-1219, 2003.

J. Dumas, C. Vandelden, K. Perron, and T. Köhler, Analysis of antibiotic resistance gene expression in Pseudomonas aeruginosa by quantitative real-time-PCR, FEMS Microbiol. Lett, vol.254, pp.217-225, 2006.

F. El'garch, K. Jeannot, D. Hocquet, C. Llanes-barakat, and P. Plésiat, Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides, Antimicrob. Agents Chemother, vol.51, pp.1016-1021, 2007.

K. Evans, L. Adewoye, and K. Poole, MexR repressor of the mexABoprM multidrug efflux operon of Pseudomonas aeruginosa: identification of MexR binding sites in the mexA-mexR intergenic region, J. Bacteriol, vol.183, pp.807-812, 2001.

J. E. Foweraker, C. R. Laughton, D. F. Brown, and D. Bilton, Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing, J. Antimicrob. Chemother, vol.55, pp.921-927, 2005.

J. A. Fyfe and J. R. Govan, Chromosomal loci associated with antibiotic hypersensitivity in pulmonary isolates of Pseudomonas aeruginosa, J. Gen. Microbiol, vol.130, pp.825-834, 1984.

J. L. Gaillard, P. Cahen, C. Delacourt, C. Silly, M. L. Bourgeois et al., Correlation between activity of beta-lactam agents in vitro and bacteriological outcome in acute pulmonary exacerbations of cystic fibrosis, Eur. J. Clin. Microbiol. Infect. Dis, vol.14, pp.291-296, 1995.

B. Giwercman, P. A. Lambert, V. T. Rosdahl, G. H. Shand, and N. Høiby, Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed -lactamase producing strains, J. Antimicrob. Chemother, vol.26, pp.247-259, 1990.

B. Giwercman, C. Meyer, P. A. Lambert, C. Reinert, and N. Høiby, High-level -lactamase activity in sputum samples from cystic fibrosis patients during antipseudomonal treatment, Antimicrob. Agents Chemother, vol.36, pp.71-76, 1992.

A. J. Godfrey, L. E. Bryan, and H. R. Rabin, Lactam-resistant Pseudomonas aeruginosa with modified penicillin-binding proteins emerging during cystic fibrosis treatment, Antimicrob. Agents Chemother, vol.19, pp.705-711, 1981.

N. Gotoh, H. Tsujimoto, M. Tsuda, K. Okamoto, A. Nomura et al., Characterization of the MexC-MexDOprJ multidrug efflux system in delta mexA-mexB-oprM mutants of Pseudomonas aeruginosa, Antimicrob. Agents Chemother, vol.42, pp.1938-1943, 1998.

J. W. Govan, Multidrug-resistant pulmonary infection in cystic fibrosis-what does "resistant" mean?, J. Med. Microbiol, vol.55, pp.1615-1617, 2006.

L. Guan and T. Nakae, Identification of essential charged residues in transmembrane segments of the multidrug transporter MexB of Pseudomonas aeruginosa, J. Bacteriol, vol.183, pp.1734-1739, 2001.

R. E. Hancock, L. M. Mutharia, L. Chan, R. P. Darveau, D. P. Speert et al., Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypeable strains deficient in lipopolysaccharide O side chains, Infect. Immun, vol.42, pp.170-177, 1983.

T. T. Hoang, R. R. Karkhoff-schweizer, A. J. Kutchma, and H. P. Schweizer, A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants, Gene, vol.212, pp.77-86, 1998.

D. Hocquet, P. Berthelot, M. Roussel-delvallez, R. Favre, K. Jeannot et al.,

G. Husson, P. Couedic, and . Plésiat, Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections, Antimicrob. Agents Chemother, vol.51, pp.3531-3536, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00464781

D. Hocquet, X. Bertrand, T. Köhler, D. Talon, and P. Plésiat, Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone, Antimicrob. Agents Chemother, vol.47, pp.1887-1894, 2003.

, EFFLUX IN P. AERUGINOSA ISOLATES FROM CF PATIENTS, vol.53, 1995.

D. Hocquet, P. Nordmann, F. El'garch, L. Cabanne, and P. Plésiat, Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa, Antimicrob. Agents Chemother, vol.50, pp.1347-1351, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00464785

D. Hocquet, C. Vogne, F. El'garch, A. Vejux, N. Gotoh et al., MexXY-OprM efflux pump is necessary for adaptive resistance of Pseudomonas aeruginosa to aminoglycosides, Antimicrob. Agents Chemother, vol.47, pp.1371-1375, 2003.

J. C. Hurley, G. H. Miller, and A. L. Smith, Mechanism of amikacin resistance in Pseudomonas aeruginosa isolates from patients with cystic fibrosis, Diagn. Microbiol. Infect. Dis, vol.22, pp.331-336, 1995.

R. T. Irvin, J. W. Govan, J. A. Fyfe, and J. W. Costerton, Heterogeneity of antibiotic resistance in mucoid isolates of Pseudomonas aeruginosa obtained from cystic fibrosis patients: role of outer membrane proteins, Antimicrob. Agents Chemother, vol.19, pp.1056-1063, 1981.

S. Islam, S. Jalal, and B. Wretling, Expression of the MexXY efflux pump in amikacin-resistant isolates of Pseudomonas aeruginosa, Clin. Microbiol. Infect, vol.10, pp.877-883, 2004.

K. Jeannot, S. Elsen, T. Köhler, I. Attree, C. et al., Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump, Antimicrob. Agents Chemother, vol.52, pp.2455-2462, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00496242

K. Jeannot, M. L. Sobel, F. E. Garch, K. Poole, and P. Plésiat, Induction of the MexXY efflux pump in Pseudomonas aeruginosa is dependent on drug-ribosome interaction, J. Bacteriol, vol.187, pp.5341-5346, 2005.
URL : https://hal.archives-ouvertes.fr/hal-01696215

J. T. Jo, F. S. Brinkman, and R. E. Hancock, Aminoglycoside efflux in Pseudomonas aeruginosa: involvement of novel outer membrane proteins, Antimicrob. Agents Chemother, vol.47, pp.1101-1111, 2003.

N. T. Keen, S. Tamaki, D. Kobayashi, and D. Trollinger, Improved broad-host-range plasmids for DNA cloning in gram-negative bacteria, Gene, vol.70, pp.191-197, 1988.

T. Köhler, M. Kok, M. Michéa-hamzehpour, P. Plésiat, N. Gotoh et al., Multidrug efflux in intrinsic resistance to trimethoprim and sulfamethoxazole in Pseudomonas aeruginosa, Antimicrob. Agents Chemother, vol.40, pp.2288-2290, 1996.

T. Köhler, M. Michéa-hamzehpour, U. Henze, N. Gotoh, L. K. Curty et al., Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa, Mol. Microbiol, vol.23, pp.345-354, 1997.

T. Köhler, M. Michéa-hamzehpour, P. Plésiat, A. L. Kahr, and J. C. Pechère, Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa, Antimicrob. Agents Chemother, vol.41, pp.2540-2543, 1997.

X. Li, L. Zhang, R. Srikumar, and K. Poole, Lactamase inhibitors are substrates for the multidrug efflux pumps of Pseudomonas aeruginosa, Antimicrob. Agents Chemother, vol.42, pp.399-403, 1998.

X. Z. Li, H. Nikaido, and K. Poole, Role of MexA-MexB-OprM in antibiotic efflux in Pseudomonas aeruginosa, Antimicrob. Agents Chemother, vol.39, pp.1948-1953, 1995.

X. Z. Li, L. Zhang, and K. Poole, Interplay between the MexA-MexBOprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa, J. Antimicrob. Chemother, vol.45, pp.433-436, 2000.

Y. Li, T. Mima, Y. Komori, Y. Morita, T. Kuroda et al., A new member of the tripartite multidrug efflux pumps, MexVW-OprM, in Pseudomonas aeruginosa, J. Antimicrob. Chemother, vol.52, pp.572-575, 2003.

C. Llanes, D. Hocquet, C. Vogne, D. Benali-baitich, C. Neuwirth et al., Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously, Antimicrob. Agents Chemother, vol.48, pp.1797-1802, 2004.
URL : https://hal.archives-ouvertes.fr/hal-01696285

J. B. Lyczack, C. L. Cannon, and G. B. Pier, Lung infections associated with cystic fibrosis, Clin. Microbiol. Rev, vol.15, pp.194-222, 2002.

D. L. Macleod, L. E. Nelson, R. M. Shawar, B. B. Lin, L. G. Lockwood et al., Aminoglycosideresistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment, J. Infect. Dis, vol.181, pp.1180-1184, 2000.

E. Mahenthiralingam, M. E. Campbell, J. Foster, J. S. Lam, and D. P. Speert, Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis, J. Clin. Microbiol, vol.34, pp.1129-1135, 1996.

H. Maseda, H. Yoneyama, and T. Nakae, Assignment of the substrateselective subunits of the MexEF-OprN multidrug efflux pump of Pseudomonas aeruginosa, Antimicrob. Agents Chemother, vol.44, pp.658-664, 2000.

N. Masuda, N. Gotoh, C. Ishii, E. Sakagawa, S. Ohya et al., Interplay between chromosomal -lactamase and the MexAB-OprM efflux system in intrinsic resistance to -lactams in Pseudomonas aeruginosa, Antimicrob. Agents Chemother, vol.43, pp.400-402, 1999.

N. Masuda, E. Sakagawa, S. Ohya, N. Gotoh, H. Tsujimoto et al., Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXYOprM efflux pumps in Pseudomonas aeruginosa, Antimicrob. Agents Chemother, vol.44, pp.3322-3327, 2000.

Y. Matsuo, S. Eda, N. Gotoh, E. Yoshihara, and T. Nakae, MexZmediated regulation of mexXY multidrug efflux pump expression in Pseudomonas aeruginosa by binding on the mexZ-mexX intergenic DNA, FEMS Microbiol. Lett, vol.238, pp.23-28, 2004.

J. R. May and A. Ingold, Sensitivity of respiratory strains of Pseudomonas aeruginosa to carbenicillin, J. Med. Microbiol, vol.6, pp.77-82, 1973.

M. Michéa-hamzehpour, J. C. Pechère, P. Plésiat, and T. Köhler, OprK and OprM define two genetically distinct multidrug efflux systems in Pseudomonas aeruginosa, Antimicrob. Agents Chemother, vol.39, pp.2392-2396, 1995.

J. K. Middlemiss and K. Poole, Differential impact of MexB mutations on substrate selectivity of the MexAB-OprM multidrug efflux pump of Pseudomonas aeruginosa, J. Bacteriol, vol.186, pp.1258-1269, 2004.

V. V. Mokhonov, E. I. Mokhonova, H. Akama, and T. Nakae, Role of the membrane fusion protein in the assembly of resistance-nodulation-cell division multidrug efflux pump in Pseudomonas aeruginosa, Biochem. Biophys. Res. Com, vol.322, pp.483-489, 2004.

S. Moreau-marquis, B. A. Stanton, and G. A. O'toole, Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway, Pulm. Pharmacol. Ther, vol.21, pp.595-599, 2008.

H. Mouneimné, J. Robert, V. Jarlier, and E. Cambau, Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa, Antimicrob. Agents Chemother, vol.43, pp.62-66, 1999.

S. Murakami, R. Nakashima, E. Yamashita, and A. Yamaguchi, Crystal structure of bacterial multidrug efflux transporter AcrB, Nature, vol.419, pp.587-593, 2002.

T. Nakae, A. Nakajima, T. Ono, K. Saito, and H. Yoneyama, Resistance to -lactam antibiotics in Pseudomonas aeruginosa due to interplay between the MexAB-OprM efflux pump and -lactamase, Antimicrob. Agents Chemother, vol.43, pp.1301-1303, 1999.

D. Nehme, X. Li, R. Elliot, and K. Poole, Assembly of the MexABOprM multidrug efflux system of Pseudomonas aeruginosa: identification and characterization of mutations in mexA compromising MexA multimerization and interaction with MexB, J. Bacteriol, vol.186, pp.2973-2983, 2004.

D. Nehme and K. Poole, Interaction of the MexA and MexB components of the MexAB-OprM multidrug efflux system of Pseudomonas aeruginosa: identification of MexA extragenic suppressors of a T578I mutation in MexB, Antimicrob. Agents Chemother, vol.49, pp.4375-4378, 2005.

J. D. Perry, L. Laine, S. Hughes, A. Nicholson, A. Galloway et al., Recovery of antimicrobial-resistant Pseudomonas aeruginosa from sputa of cystic fibrosis patients by culture on selective media, J. Antimicrob. Chemother, vol.61, pp.1057-1061, 2008.

K. Poole, D. E. Heinrichs, and S. Neshat, Cloning and sequence analysis of an EnvCD homologue in Pseudomonas aeruginosa: regulation by iron and possible involvement in the secretion of the siderophore pyoverdine, Mol. Microbiol, vol.10, pp.529-544, 1993.

K. Poole, K. Tetro, Q. X. Zhao, S. Neshat, D. E. Heinrichs et al., Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression, Antimicrob. Agents Chemother, vol.40, pp.2021-2028, 1996.

L. Quenee, D. Lamotte, and B. Polack, Combined sacB-based negative selection and cre-lox antibiotic marker recycling for efficient deletion in Pseudomonas aeruginosa, BioTechniques, vol.38, pp.63-67, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00399228

J. Ramos-aires, T. Köhler, H. Nikaido, and P. Plésiat, Involvement of an efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides, Antimicrob. Agents Chemother, vol.43, pp.2624-2628, 1999.

B. W. Ramsey, Management of pulmonary disease in patients with cystic fibrosis, N. Engl. J. Med, vol.335, pp.179-188, 1996.

B. W. Ramsey, M. S. Pepe, J. M. Quan, K. L. Otto, A. B. Montgomery et al., Intermittent administration of inhaled tobramycin in patients with cystic fibrosis, N. Engl. J. Med, vol.340, pp.23-30, 1999.

K. Saito, S. Eda, H. Maseda, and T. Nakae, Molecular mechanism of MexR-mediated regulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa, FEMS Microbiol. Lett, vol.195, pp.23-28, 2001.

T. W. Seale, H. Thirkill, M. Tarpay, M. Flux, and O. M. Rennert, Serotypes and antibiotic susceptibilities of Pseudomonas aeruginosa isolates from single sputa of cystic fibrosis patients, J. Clin. Microbiol, vol.9, pp.72-78, 1979.

R. M. Shawar, D. L. Macleod, R. L. Garber, J. L. Burns, J. R. Stapp et al., Activities of tobramycin and six other antibiotics against Pseudomonas aeruginosa isolates from patients with cystic fibrosis, Antimicrob. Agents Chemother, vol.43, pp.2877-2880, 1999.

K. Shimizu, T. Kumada, W. Hsieh, H. Chung, Y. Chong et al., Comparison of aminoglycoside resistance patterns in Japan, Antimicrob. Agents Chemother, vol.28, pp.282-288, 1985.

R. Simon, U. Prieffer, and A. Pühler, Vector plasmids for in vivo and in vitro manipulations of gram-negative bacteria, Molecular genetics of the bacteria-plant interaction, pp.98-106, 1983.

A. L. Smith, S. B. Fiel, N. Mayer-hamblett, B. Ramsey, and J. L. Burns, Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration, Chest, vol.123, pp.1495-1502, 2003.

A. W. Smith and B. H. Iglewski, Transformation of Pseudomonas aeruginosa by electroporation, Nucleic Acids Res, vol.17, p.10509, 1989.

E. E. Smith, D. G. Buckley, Z. Wu, C. Saenphimmachak, L. R. Hoffman et al., Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients, Proc. Natl. Acad. Sci. USA, vol.103, pp.8487-8492, 2006.

M. L. Sobel, D. Hocquet, L. Cao, P. Plésiat, and K. Poole, Mutations in PA3574 (nalD) lead to increased MexAB-OprM expression and multidrug resistance in laboratory and clinical isolates of Pseudomonas aeruginosa, Antimicrob. Agents Chemother, vol.49, pp.1782-1786, 2005.
URL : https://hal.archives-ouvertes.fr/hal-01696230

M. L. Sobel, G. A. Mckay, and K. Poole, Contribution of the MexXY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates, Antimicrob. Agents Chemother, vol.47, pp.3202-3207, 2003.

A. L. Spoering and K. Lewis, Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials, J. Bacteriol, vol.183, pp.6746-6751, 2001.

R. Srikumar, T. Kon, N. Gotoh, and K. Poole, Expression of Pseudomonas aeruginosa multidrug efflux pumps MexA-MexB-OprM and MexCMexD-OprJ in a multidrug-sensitive Escherichia coli strain, Antimicrob. Agents Chemother, vol.42, pp.65-71, 1998.

R. Srikumar, X. Z. Li, and K. Poole, Inner membrane efflux components are responsible for -lactam specificity of multidrug efflux pumps in Pseudomonas aeruginosa, J. Bacteriol, vol.179, pp.7875-7881, 1997.

D. D. Sriramulu, H. Lünsdorf, J. S. Lam, and U. Römling, Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung, J. Med. Microbiol, vol.54, pp.667-676, 2005.

C. K. Stover, X. Q. Pham, A. L. Erwin, S. D. Mizoguchi, P. Warrener et al.,

F. S. Hickey, W. O. Brinkman, D. J. Hufnagle, M. Kowalik, R. L. Lagrou et al.,

S. N. Brody, K. R. Coulter, A. Folger, K. Kas, R. Larbig et al., Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen, Nature, vol.406, pp.959-964, 2000.

C. Vogne, J. Ramos-aires, C. Bailly, D. Hocquet, and P. Plésiat, Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis, Antimicrob. Agents Chemother, vol.48, pp.1676-1680, 2004.
URL : https://hal.archives-ouvertes.fr/hal-01696291

S. Westbrock-wadman, D. R. Sherman, M. J. Hickey, S. N. Coulter, Y. Q. Zhu et al., Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability, Antimicrob. Agents Chemother, vol.43, pp.2975-2983, 1999.

C. Yanisch-perron, J. Vieria, and J. Messing, Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13 mp18 and pUC19 vectors, Gene, vol.33, pp.103-119, 1985.

H. Yoneyama, H. Maseda, T. Yamabayashi, S. Izumi, and T. Nakae, Secondary-site mutations restore the transport defect caused by the transmembrane domain mutation of the xenobiotic transporter MexB in Pseudomonas aeruginosa, Biochem. Biophys. Res. Com, vol.292, pp.513-518, 2002.

E. W. Yu, J. R. Aires, and H. Nikaido, AcrB multidrug efflux pump of Escherichia coli: composite substrate-binding cavity of exceptional flexibility generates its extremely wide substrate specificity, J. Bacteriol, vol.185, pp.5657-5664, 2003.

Q. Zhao and K. Poole, Differential effects of mutations in tonB1 on intrinsic multidrug resistance and iron acquisition in Pseudomonas aeruginosa, Antimicrob. Agents Chemother, vol.184, pp.2045-2049, 2002.

, EFFLUX IN P. AERUGINOSA ISOLATES FROM CF PATIENTS, vol.53, 1997.

S. Aendekerk, B. Ghysels, P. Cornelis, and C. Baysse, Characterization of a new efflux pump, MexGHI-OpmD, from Pseudomonas aeruginosa that confers resistance to vanadium, Microbiology, vol.148, pp.2371-81, 2002.

J. R. Aires, T. Köhler, H. Nikaido, and P. Plesiat, Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides, Antimicrob Agents Chemother, vol.43, issue.11, pp.2624-2632, 1999.

J. R. Aires, J. C. Pechere, C. Van-delden, and T. Köhler, Amino acid residues essential for function of the MexF efflux pump protein of Pseudomonas aeruginosa, Antimicrob Agents Chemother, vol.46, issue.7, pp.2169-73, 2002.

H. Akama, M. Kanemaki, M. Yoshimura, T. Tsukihara, T. Kashiwagi et al., Crystal structure of the drug discharge outer membrane protein, OprM, of Pseudomonas aeruginosa: dual modes of membrane anchoring and occluded cavity end, J Biol Chem, vol.279, issue.51, pp.52816-52825, 2004.

H. Akama, T. Matsuura, S. Kashiwagi, H. Yoneyama, S. Narita et al., Crystal structure of the membrane fusion protein, MexA, of the multidrug transporter in Pseudomonas aeruginosa, J Biol Chem, vol.279, issue.25, pp.25939-25981, 2004.

T. Akasaka, M. Tanaka, A. Yamaguchi, and K. Sato, Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance, Antimicrob. Agents Chemother, vol.45, issue.8, pp.2263-2271, 2001.

M. P. Anderson, R. J. Gregory, S. Thompson, D. W. Souza, S. Paul et al., Demonstration that CFTR is a chloride channel by alteration of its anion selectivity, Science, vol.253, issue.5016, pp.202-207, 1991.

F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman et al., Current protocols in molecular biology, 2000.

N. Bagge, O. Ciofu, M. Hentzer, J. I. Campbell, M. Givskov et al., Constitutive high expression of chromosomal beta-lactamase in Pseudomonas aeruginosa caused by a new insertion sequence (IS1669) located in ampD, Antimicrob Agents Chemother, vol.46, issue.11, pp.3406-3417, 2002.

N. Bagge, M. Hentzer, J. B. Andersen, O. Ciofu, M. Givskov et al., Dynamics and spatial distribution of beta-lactamase expression in Pseudomonas aeruginosa biofilms, Antimicrob Agents Chemother, vol.48, issue.4, pp.1168-74, 2004.

S. Ballestero, A. Fernandez-rodriguez, R. Villaverde, H. Escobar, J. C. Perez-diaz et al., Carbapenem resistance in Pseudomonas aeruginosa from cystic fibrosis patients, J Antimicrob Chemother, vol.38, issue.1, pp.39-45, 1996.

M. L. Barclay and E. J. Begg, Aminoglycoside adaptive resistance: importance for effective dosage regimens, Drugs, vol.61, issue.6, pp.713-734, 2001.

M. L. Barclay, E. J. Begg, S. T. Chambers, P. E. Thornley, P. K. Pattemore et al., Adaptive resistance to tobramycin in Pseudomonas aeruginosa lung infection in cystic fibrosis, J Antimicrob Chemother, vol.37, issue.6, pp.1155-64, 0200.

F. Becq, Arch Pediatr, vol.10, pp.325-332, 2003.

F. Bert and N. Lambert-zechovsky, Comparative distribution of resistance patterns and serotypes in Pseudomonas aeruginosa isolates from intensive care units and other wards, J Antimicrob Chemother, vol.37, issue.4, pp.809-822, 1996.

T. Bienvenu, , 2003.

, Arch Pediatr, vol.10, pp.318-324

S. Biswas, M. M. Mohammad, D. R. Patel, L. Movileanu, . Van-den et al., Structural insight into OprD substrate specificity, Nat Struct Mol Biol, vol.14, issue.11, pp.1108-1117, 2007.

J. A. Bohnert, S. Schuster, E. Fahnrich, R. Trittler, and W. V. Kern, , 2007.

, Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF), J Antimicrob Chemother, vol.59, issue.6, pp.1216-1238

G. Borriello, E. Werner, F. Roe, A. M. Kim, G. D. Ehrlich et al., Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms, Antimicrob Agents Chemother, vol.48, issue.7, pp.2659-64, 2004.

, British Society of Antimicrobial Chemotherapy, BSAC, 2008.

J. L. Burns, L. Saiman, S. Whittier, D. Larone, J. Krzewinski et al.,

S. A. Marshall and R. N. Jones, Comparison of agar diffusion methodologies for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients, J Clin Microbiol, vol.38, issue.5, pp.1818-1840, 2000.

. Ca-sfm, Comité de l'Antibiogramme de la Société Française de Microbiologie, 2008.

J. I. Campbell, O. Ciofu, and N. Hoiby, Pseudomonas aeruginosa isolates from patients with cystic fibrosis have different beta-lactamase expression phenotypes but are homogeneous in the ampC-ampR genetic region, Antimicrob Agents Chemother, vol.41, issue.6, pp.1380-1384, 1997.

L. Cao, R. Srikumar, and K. Poole, MexAB-OprM hyperexpression in NalC-type multidrug-resistant Pseudomonas aeruginosa: identification and characterization of the nalC gene encoding a repressor of PA3720-PA3719, Mol Microbiol, vol.53, issue.5, pp.1423-1459, 2004.

O. Cardoso, A. F. Alves, and R. Leitao, Metallo-beta-lactamase VIM-2 in Pseudomonas aeruginosa isolates from a cystic fibrosis patient, Int J Antimicrob Agents, vol.31, issue.4, pp.375-384, 2008.

J. D. Cavallo, F. Leblanc, and R. Fabre, Surveillance of Pseudomonas aeruginosa sensitivity to antibiotics in France and distribution of beta-lactam resistance mechanisms: 1998 GERPB study, 2000.

, Pathol Biol (Paris), vol.48, issue.5, pp.472-479

J. D. Cavallo, F. Leblanc, R. Fabre, and A. Fourticq-esqueoute, Survey of the antibiotic sensitivity of Pseudomonas aeruginosa in France and the distribution of beta, 2001.

, Pathol Biol

R. Chuanchuen, K. Beinlich, T. T. Hoang, A. Becher, and R. Karkhoff-schweizer,

R. Schweizer and H. P. , Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ, Antimicrob Agents Chemother, vol.45, issue.2, pp.428-460, 2001.

R. Chuanchuen, C. T. Narasaki, and H. P. Schweizer, The MexJK efflux pump of Pseudomonas aeruginosa requires OprM for antibiotic efflux but not for efflux of triclosan, J Bacteriol, vol.184, issue.18, pp.5036-5080, 2002.

, CLSI, 2006.

, Prise en charge du patient atteint de mucoviscidose, Conférence de Consensus, 2002.

D. M. Daigle, L. Cao, S. Fraud, M. S. Wilke, A. Pacey et al., Protein modulator of multidrug efflux gene expression in Pseudomonas aeruginosa, J Bacteriol, vol.189, issue.15, pp.5441-51, 2007.

D. M. Daigle, K. Poole, and C. R. Dean, RifAB (PA1540-PA1541) is an SMR Efflux Pump and Major Contributor to Multidrug Resistance in Pseudomonas aeruginosa, Pseudomonas, p.95, 2007.

G. L. Daikos, G. G. Jackson, V. T. Lolans, and D. M. Livermore, , 1990.

, Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation, J Infect Dis, vol.162, issue.2, pp.414-434

G. L. Daikos, V. T. Lolans, and G. G. Jackson, First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use, Antimicrob Agents Chemother, vol.35, issue.1, pp.117-140, 1991.

T. R. De-kievit and J. S. Lam, Isolation and characterization of two genes, waaC (rfaC) and waaF (rfaF), involved in Pseudomonas aeruginosa serotype O5 innercore biosynthesis, J Bacteriol, vol.179, issue.11, pp.3451-3458, 1997.

V. De-lorenzo and K. N. Timmis, Analysis and construction of stable phenotypes in gram-negative bacteria with Tn5-and Tn10-derived minitransposons, Methods Enzymol, vol.235, pp.386-405, 1994.

C. R. Dean, M. A. Visalli, S. J. Projan, P. E. Sum, and P. A. Bradford, , 2003.

, Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1, Antimicrob Agents Chemother, vol.47, issue.3, pp.972-980

J. M. Diver, L. E. Bryan, and P. A. Sokol, Transformation of Pseudomonas aeruginosa by electroporation, Anal Biochem, vol.189, issue.1, pp.75-84, 1990.

E. Drenkard, Antimicrobial resistance of Pseudomonas aeruginosa biofilms, Microbes Infect, vol.5, issue.13, pp.1213-1222, 2003.

E. Drenkard and F. M. Ausubel, Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation, Nature, vol.416, issue.6882, pp.740-743, 2002.

V. Dubois, C. Arpin, V. Dupart, A. Scavelli, L. Coulange et al., Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres), J Antimicrob Chemother, vol.62, issue.2, pp.316-339, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00319141

J. L. Dumas, C. Van-delden, K. Perron, and T. Köhler, Analysis of antibiotic resistance gene expression in Pseudomonas aeruginosa by quantitative realtime-PCR, FEMS Microbiol Lett, vol.254, issue.2, pp.217-242, 2006.

F. El'garch, K. Jeannot, D. Hocquet, C. Llanes-barakat, and P. Plesiat, , 2007.

, Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides, Antimicrob Agents Chemother, vol.51, issue.3, pp.1016-1037

X. Estivill, C. Bancells, and C. Ramos, Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. The Biomed CF Mutation Analysis Consortium, Hum Mutat, vol.10, issue.2, pp.135-54, 1997.

J. C. Evans and H. Segal, A novel insertion sequence, ISPA26, in oprD of Pseudomonas aeruginosa is associated with carbapenem resistance, Antimicrob Agents Chemother, vol.51, issue.10, pp.3776-3783, 2007.

K. Evans, L. Adewoye, and K. Poole, MexR repressor of the mexAB-oprM multidrug efflux operon of Pseudomonas aeruginosa: identification of MexR binding sites in the mexA-mexR intergenic region, J Bacteriol, vol.183, issue.3, pp.807-819, 2001.

M. E. Falagas and S. K. Kasiakou, Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections, Clin Infect Dis, vol.40, issue.9, pp.1333-1374, 2005.

J. E. Foweraker, C. R. Laughton, D. F. Brown, and D. Bilton, Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing, J Antimicrob Chemother, vol.55, issue.6, pp.921-928, 2005.

M. Galimand, P. Courvalin, and T. Lambert, Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation, Antimicrob Agents Chemother, vol.47, issue.8, pp.2565-71, 2003.

R. L. Gibson, J. Emerson, S. Mcnamara, J. L. Burns, M. Rosenfeld et al., Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis, Am J Respir Crit Care Med, vol.167, issue.6, pp.841-850, 2003.

M. I. Gillham, S. Sundaram, C. R. Laughton, C. S. Haworth, D. Bilton et al., Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis, J Antimicrob Chemother, vol.63, issue.4, pp.728-760, 2009.

D. Girlich, T. Naas, and P. Nordmann, Biochemical characterization of the naturally occurring oxacillinase OXA-50 of Pseudomonas aeruginosa, Antimicrob Agents Chemother, vol.48, issue.6, pp.2043-2051, 2004.

C. G. Giske, L. Buaro, A. Sundsfjord, and B. Wretlind, Alterations of porin, pumps, and penicillin-binding proteins in carbapenem resistant clinical isolates of Pseudomonas aeruginosa, Microb Drug Resist, vol.14, issue.1, pp.23-30, 2008.

B. Giwercman, P. A. Lambert, V. T. Rosdahl, G. H. Shand, and N. Hoiby, Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis 203 patients due to in-vivo selection of stable partially derepressed beta-lactamase producing strains, J Antimicrob Chemother, vol.26, issue.2, pp.247-59, 1990.

A. J. Godfrey, L. E. Bryan, and H. R. Rabin, beta-Lactam-resistant Pseudomonas aeruginosa with modified penicillin-binding proteins emerging during cystic fibrosis treatment, Antimicrob Agents Chemother, vol.19, issue.5, pp.705-716, 1981.

N. Gotoh, H. Tsujimoto, A. Nomura, K. Okamoto, M. Tsuda et al., Functional replacement of OprJ by OprM in the MexCD-OprJ multidrug efflux system of Pseudomonas aeruginosa, FEMS Microbiol Lett, vol.165, issue.1, pp.21-28, 1998.

J. R. Govan and V. Deretic, Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia, Microbiol Rev, vol.60, issue.3, pp.539-74, 1996.

S. Grkovic, M. H. Brown, and R. A. Skurray, Regulation of bacterial drug export systems, Microbiol Mol Biol Rev, vol.66, issue.4, pp.671-701, 2002.

C. Grosskopf, J. P. Farriaux, M. Vidailhet, M. L. Briard, J. Navarro et al., National neonatal screening program for cystic fibrosis: management and organization, Arch Pediatr, vol.10, pp.364-369, 2003.

L. Guan, M. Ehrmann, H. Yoneyama, and T. Nakae, Membrane topology of the xenobiotic-exporting subunit, MexB, of the MexA,B-OprM extrusion pump in Pseudomonas aeruginosa, J Biol Chem, vol.274, issue.15, pp.10517-10539, 1999.

L. Guan and T. Nakae, Identification of essential charged residues in transmembrane segments of the multidrug transporter MexB of Pseudomonas aeruginosa, J Bacteriol, vol.183, issue.5, pp.1734-1743, 2001.

J. S. Gunn, K. B. Lim, J. Krueger, K. Kim, L. Guo et al., PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance, Mol Microbiol, vol.27, issue.6, pp.1171-82, 1998.

M. M. Hamzehpour, J. C. Pechere, P. Plésiat, and T. Köhler, OprK and OprM define two genetically distinct multidrug efflux systems in Pseudomonas aeruginosa, Antimicrob Agents Chemother, vol.39, issue.11, pp.2392-2398, 1995.

R. E. Hancock, Alterations in outer membrane permeability, Annu Rev Microbiol, vol.38, pp.237-64, 1984.

R. E. Hancock, L. M. Mutharia, L. Chan, R. P. Darveau, D. P. Speert et al., Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains, Infect Immun, vol.42, issue.1, pp.170-177, 1983.

R. E. Hancock and P. G. Wong, Compounds which increase the permeability of the Pseudomonas aeruginosa outer membrane, Antimicrob Agents Chemother, vol.26, issue.1, pp.48-52, 1984.

D. J. Hassett, J. Cuppoletti, B. Trapnell, S. V. Lymar, J. J. Rowe et al., Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis, Antimicrob Agents Chemother, vol.47, issue.3, pp.1101-1112, 2002.

H. K. Johansen, S. M. Moskowitz, O. Ciofu, T. Pressler, and N. Hoiby, , 2008.

, Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients, J Cyst Fibros, vol.7, issue.5, pp.391-397

C. Juan, M. D. Macia, O. Gutierrez, C. Vidal, J. L. Perez et al., Molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains, Antimicrob Agents Chemother, vol.49, issue.11, pp.4733-4741, 2005.

C. Juan, B. Moya, J. L. Perez, and A. Oliver, Stepwise upregulation of the Pseudomonas aeruginosa chromosomal cephalosporinase conferring high-level beta-lactam resistance involves three AmpD homologues, Antimicrob Agents Chemother, vol.50, issue.5, pp.1780-1787, 2006.

T. Okazaki and K. Hirai, Cloning and nucleotide sequence of the Pseudomonas aeruginosa nfxB gene, conferring resistance to new quinolones, FEMS Microbiol Lett, vol.76, issue.1-2, pp.197-202, 1992.

A. Oliver, R. Canton, P. Campo, F. Baquero, and J. Blazquez, High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection, Science, vol.288, issue.5469, pp.1251-1255, 2000.

H. Pai, J. Kim, J. H. Lee, K. W. Choe, and N. Gotoh, Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates, Antimicrob Agents Chemother, vol.45, issue.2, pp.480-484, 2001.

I. T. Paulsen, M. H. Brown, and R. A. Skurray, Proton-dependent multidrug efflux systems, Microbiol Rev, vol.60, issue.4, pp.575-608, 1996.

M. W. Pfaffl, G. W. Horgan, and L. Dempfle, Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR, Nucleic Acids Res, vol.30, issue.9, p.36, 2002.

T. L. Pitt, M. Sparrow, M. Warner, and M. Stefanidou, Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents, Thorax, vol.58, issue.9, pp.794-800, 2003.

K. Poole, Efflux-mediated multiresistance in Gram-negative bacteria, Clin Microbiol Infect, vol.10, issue.1, pp.12-26, 2004.

K. Poole, Aminoglycoside resistance in Pseudomonas aeruginosa, 2005.

, Antimicrob Agents Chemother, vol.49, issue.2, pp.479-87

K. Poole, N. Gotoh, H. Tsujimoto, Q. Zhao, A. Wada et al., Overexpression of the mexCmexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa, Mol Microbiol, vol.21, issue.4, pp.713-737, 1996.

K. Poole, D. E. Heinrichs, and S. Neshat, Cloning and sequence analysis of an EnvCD homologue in Pseudomonas aeruginosa: regulation by iron and possible involvement in the secretion of the siderophore pyoverdine, Mol Microbiol, vol.10, issue.3, pp.529-573, 1993.

K. Poole, K. Krebes, C. Mcnally, and S. Neshat, Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon, J Bacteriol, vol.175, issue.22, pp.7363-72, 1993.

K. Poole, K. Tetro, Q. Zhao, S. Neshat, D. E. Heinrichs et al., Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression, Antimicrob Agents Chemother, vol.40, issue.9, pp.2021-2029, 1996.

L. Quenee, D. Lamotte, and B. Polack, Combined sacB-based negative selection and cre-lox antibiotic marker recycling for efficient gene deletion in Pseudomonas aeruginosa, Biotechniques, vol.38, issue.1, pp.63-70, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00399228

L. G. Rahme, E. J. Stevens, S. F. Wolfort, J. Shao, and R. G. Tompkins,

F. M. Ausubel, Common virulence factors for bacterial pathogenicity in plants and animals, Science, vol.268, issue.5219, pp.1899-902, 1995.

B. W. Ramsey, Management of pulmonary disease in patients with cystic fibrosis, N Engl J Med, vol.335, issue.3, pp.179-88, 1996.

F. Ratjen and G. Doring, Cystic fibrosis, Lancet, vol.361, issue.9358, pp.681-690, 2003.
URL : https://hal.archives-ouvertes.fr/hal-01361411

G. Rault, M. Roussey, B. Desrues, D. Turck, T. Perez et al., , 2001.

, Arch Pediatr, vol.8, pp.802-817

J. R. Riordan, The cystic fibrosis transmembrane conductance regulator, Annu Rev Physiol, vol.55, pp.609-639, 1993.

M. Rivera, L. E. Bryan, R. E. Hancock, and E. J. Mcgroarty, , 1988.

, Heterogeneity of lipopolysaccharides from Pseudomonas aeruginosa: analysis of lipopolysaccharide chain length, J Bacteriol, vol.170, issue.2, pp.512-533

M. Rivera, R. E. Hancock, J. G. Sawyer, A. Haug, and E. J. Mcgroarty, Enhanced binding of polycationic antibiotics to lipopolysaccharide from an aminoglycoside-supersusceptible, tolA mutant strain of Pseudomonas aeruginosa, Antimicrob Agents Chemother, vol.32, issue.5, pp.649-55, 1988.

M. Rivera and E. J. Mcgroarty, Analysis of a common-antigen lipopolysaccharide from Pseudomonas aeruginosa, J Bacteriol, vol.171, issue.4, pp.2244-2252, 1989.

H. L. Rocchetta, L. L. Burrows, and J. S. Lam, Genetics of O-antigen biosynthesis in Pseudomonas aeruginosa, Microbiol Mol Biol Rev, vol.63, issue.3, pp.523-53, 1999.

J. M. Rommens, M. C. Iannuzzi, B. Kerem, M. L. Drumm, G. Melmer et al., , 1989.

, Identification of the cystic fibrosis gene: chromosome walking and jumping, Science, vol.245, issue.4922, pp.1059-65

S. M. Rowe, S. Miller, and E. J. Sorscher, Cystic fibrosis, N Engl J Med, vol.352, pp.1992-2001, 2005.

L. Saiman, Clinical utility of synergy testing for multidrug-resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis: 'the motion for', Paediatr Respir Rev, vol.8, issue.3, pp.249-55, 2007.

L. Saiman, J. L. Burns, S. Whittier, J. Krzewinski, S. A. Marshall et al., Evaluation of reference dilution test methods for antimicrobial susceptibility testing of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis, J Clin Microbiol, vol.37, issue.9, pp.2987-91, 1999.

F. Sanger, S. Nicklen, and A. R. Coulson, DNA sequencing with chainterminating inhibitors, Proc Natl Acad Sci U S A, vol.74, issue.12, pp.5463-5470, 1977.

K. Sauer, The genomics and proteomics of biofilm formation, Genome Biol, vol.4, issue.6, p.219, 2003.

K. Sauer, M. C. Cullen, A. H. Rickard, L. A. Zeef, D. G. Davies et al., Characterization of nutrient-induced dispersion in Pseudomonas aeruginosa PAO1 biofilm, J Bacteriol, vol.186, issue.21, pp.7312-7338, 2004.

A. J. Schmidtke and N. D. Hanson, Role of ampD homologs in overproduction of AmpC in clinical isolates of Pseudomonas aeruginosa, Antimicrob Agents Chemother, vol.52, issue.11, pp.3922-3929, 2008.

M. Schneider, K. Muhlemann, S. Droz, S. Couzinet, and C. Casaulta,

S. Zimmerli, Clinical characteristics associated with isolation of small-colony variants of Staphylococcus aureus and Pseudomonas aeruginosa from respiratory secretions of patients with cystic fibrosis, J Clin Microbiol, vol.46, issue.5, pp.1832-1836, 2008.

H. P. Schweizer, Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions, Genet Mol Res, vol.2, issue.1, pp.48-62, 2003.

M. A. Seeger, A. Schiefner, T. Eicher, F. Verrey, K. Diederichs et al.,

, Structural asymmetry of AcrB trimer suggests a peristaltic pump mechanism, Science, vol.313, issue.5791, pp.1295-1303, 2006.

H. Sekiya, T. Mima, Y. Morita, T. Kuroda, T. Mizushima et al., Functional cloning and characterization of a multidrug efflux pump, mexHIopmD, from a Pseudomonas aeruginosa mutant, Antimicrob Agents Chemother, vol.47, issue.9, pp.2990-2992, 2003.

G. Sennhauser, P. Amstutz, C. Briand, O. Storchenegger, and M. G. Grutter, Drug export pathway of multidrug exporter AcrB revealed by DARPin inhibitors, PLoS Biol, vol.5, issue.1, p.7, 2007.

S. Shak, D. J. Capon, R. Hellmiss, S. A. Marsters, and C. L. Baker, , 1990.

, Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum, Proc Natl Acad Sci U S A, vol.87, issue.23, pp.9188-92

R. M. Shawar, D. L. Macleod, R. L. Garber, J. L. Burns, J. R. Stapp et al., Activities of tobramycin and six other antibiotics against Pseudomonas aeruginosa isolates from patients with cystic fibrosis, Antimicrob Agents Chemother, vol.43, issue.12, pp.2877-80, 1999.

M. Shigeta, G. Tanaka, H. Komatsuzawa, M. Sugai, H. Suginaka et al., Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: a simple method, Chemotherapy, vol.43, issue.5, pp.340-345, 1997.

I. Siegmund and F. Wagner, New method for detecting rhamnolipids excreted by Pseudomonas species during growth in mineral agar, Biotechnol Tech, vol.5, pp.265-268, 1991.

R. Simon, M. O'connell, M. Labes, and A. Puhler, Plasmid vectors for the genetic analysis and manipulation of rhizobia and other gram-negative bacteria, Methods Enzymol, vol.118, pp.640-59, 1986.

A. W. Smith and B. H. Iglewski, Transformation of Pseudomonas aeruginosa by electroporation, Nucleic Acids Res, vol.17, issue.24, p.10509, 1989.

E. E. Smith, D. G. Buckley, Z. Wu, C. Saenphimmachak, L. R. Hoffman et al., Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients, Proc Natl Acad Sci U S A, vol.103, issue.22, pp.8487-92, 2006.

M. L. Sobel, D. Hocquet, L. Cao, P. Plesiat, and K. Poole, Mutations in PA3574 (nalD) lead to increased MexAB-OprM expression and multidrug resistance in laboratory and clinical isolates of Pseudomonas aeruginosa, Antimicrob Agents Chemother, vol.49, issue.5, pp.1782-1788, 2005.
URL : https://hal.archives-ouvertes.fr/hal-01696230

M. L. Sobel, G. A. Mckay, and K. Poole, Contribution of the MexXY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates, Antimicrob Agents Chemother, vol.47, issue.10, pp.3202-3209, 2003.

D. D. Sriramulu, H. Lunsdorf, J. S. Lam, and U. Romling, Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung, J Med Microbiol, vol.54, pp.667-76, 2005.

C. K. Stover, X. Q. Pham, A. L. Erwin, S. D. Mizoguchi, P. Warrener et al., Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen, Nature, vol.406, issue.6799, pp.959-64, 2000.

C. C. Su, M. Li, R. Gu, Y. Takatsuka, G. Mcdermott et al.,

W. , Conformation of the AcrB multidrug efflux pump in mutants of the putative proton relay pathway, J Bacteriol, vol.188, issue.20, pp.7290-7296, 2006.

R. Szczepanowski, I. Krahn, B. Linke, A. Goesmann, A. Puhler et al., Antibiotic multiresistance plasmid pRSB101 isolated from a wastewater treatment plant is related to plasmids residing in phytopathogenic bacteria and carries eight different resistance determinants including a multidrug transport system, Microbiology, vol.150, pp.3613-3643, 2004.

E. B. Tikhonova, Q. Wang, and H. I. Zgurskaya, Chimeric analysis of the multicomponent multidrug efflux transporters from gram-negative bacteria, J Bacteriol, vol.184, issue.23, pp.6499-507, 2002.

J. Trias and H. Nikaido, Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa, Antimicrob Agents Chemother, vol.34, issue.1, pp.52-59, 1990.

J. Trias and H. Nikaido, Protein D2 channel of the Pseudomonas aeruginosa outer membrane has a binding site for basic amino acids and peptides, J Biol Chem, vol.265, issue.26, pp.15680-15684, 1990.

G. Valenza, D. Tappe, D. Turnwald, M. Frosch, C. Konig et al., Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis, J Cyst Fibros, vol.7, issue.2, pp.123-130, 2008.

P. Vasseur, C. Soscia, R. Voulhoux, and A. Filloux, PelC is a Pseudomonas aeruginosa outer membrane lipoprotein of the OMA family of proteins involved in exopolysaccharide transport, Biochimie, vol.89, issue.8, pp.903-918, 2007.

C. Vogne, J. R. Aires, C. Bailly, D. Hocquet, and P. Plesiat, Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis, Antimicrob Agents Chemother, vol.48, issue.5, pp.1676-80, 2004.
URL : https://hal.archives-ouvertes.fr/hal-01696291

H. Vu-thien, G. Corbineau, K. Hormigos, B. Fauroux, H. Corvol et al., Multiple-locus variable-number tandemrepeat analysis for longitudinal survey of sources of Pseudomonas aeruginosa infection in cystic fibrosis patients, J Clin Microbiol, vol.45, issue.10, pp.3175-83, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00192548

V. E. Wagner, J. G. Frelinger, R. K. Barth, and B. H. Iglewski, Quorum sensing: dynamic response of Pseudomonas aeruginosa to external signals, Trends Microbiol, vol.14, issue.2, pp.55-63, 2006.

M. C. Walters, F. Roe, A. Bugnicourt, M. J. Franklin, and P. S. Stewart, Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin, Antimicrob Agents Chemother, vol.47, issue.1, pp.317-340, 2003.

M. J. Welsh and A. E. Smith, Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis, Cell, vol.73, issue.7, pp.1251-1255, 1993.

E. Werner, F. Roe, A. Bugnicourt, M. J. Franklin, A. Heydorn et al., Stratified growth in Pseudomonas aeruginosa biofilms, Appl Environ Microbiol, vol.70, issue.10, pp.6188-96, 2004.

S. Westbrock-wadman, D. R. Sherman, M. J. Hickey, S. N. Coulter, Y. Q. Zhu et al., Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability, Antimicrob Agents Chemother, vol.43, issue.12, pp.2975-83, 1999.

M. Whiteley, M. G. Bangera, R. E. Bumgarner, M. R. Parsek, G. M. Teitzel et al., Gene expression in Pseudomonas aeruginosa biofilms, Nature, vol.413, issue.6858, pp.860-864, 2001.

L. Wiehlmann, G. Wagner, N. Cramer, B. Siebert, P. Gudowius et al., Population structure of Pseudomonas aeruginosa, Proc Natl Acad Sci U S A, vol.104, pp.8101-8107, 2007.

M. S. Wilke, M. Heller, A. L. Creagh, C. A. Haynes, L. P. Mcintosh et al., The crystal structure of MexR from Pseudomonas aeruginosa in complex with its antirepressor ArmR, Proc Natl Acad Sci U S A, vol.105, issue.39, pp.14832-14839, 2008.

S. G. Wilkinson, Bacterial lipopolysaccharides--themes and variations, Prog Lipid Res, vol.35, issue.3, pp.283-343, 1996.

D. J. Wozniak, T. J. Wyckoff, M. Starkey, R. Keyser, P. Azadi et al., Alginate is not a significant component of the extracellular polysaccharide matrix of PA14 and PAO1 Pseudomonas aeruginosa biofilms, Proc Natl Acad Sci U S A, vol.100, issue.13, pp.7907-7919, 2003.

Y. Q. Xiong, J. Caillon, M. F. Kergueris, H. Drugeon, D. Baron et al., Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model, Antimicrob Agents Chemother, vol.41, issue.4, pp.823-829, 1997.

C. Yanisch-perron, J. Vieira, and J. Messing, Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors, Gene, vol.33, issue.1, pp.103-122, 1985.

H. Yerushalmi, M. Lebendiker, and S. Schuldiner, EmrE, an Escherichia coli 12-kDa multidrug transporter, exchanges toxic cations and H + and is soluble in organic solvents, J Biol Chem, vol.270, issue.12, pp.6856-63, 1995.

K. Yokoyama, Y. Doi, K. Yamane, H. Kurokawa, N. Shibata et al., Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa, Lancet, vol.362, issue.9399, pp.1888-93, 2003.

H. Yoneyama, H. Maseda, T. A. Ta, S. Izumi, and T. Nakae, Secondary-site mutation restores the transport defect caused by the transmembrane domain mutation of the xenobiotic transporter MexB in Pseudomonas aeruginosa, Biochem Biophys Res Commun, vol.292, issue.2, pp.513-521, 2002.

H. Yoneyama, A. Ocaktan, N. Gotoh, T. Nishino, and T. Nakae, Subunit swapping in the Mex-extrusion pumps in Pseudomonas aeruginosa, Biochem Biophys Res Commun, vol.244, issue.3, pp.898-902, 1998.

H. Yoshida, M. Nakamura, M. Bogaki, and S. Nakamura, Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa, Antimicrob Agents Chemother, vol.34, issue.6, pp.1273-1278, 1990.

E. W. Yu, J. R. Aires, G. Mcdermott, and H. Nikaido, A periplasmic drug-binding site of the AcrB multidrug efflux pump: a crystallographic and sitedirected mutagenesis study, J Bacteriol, vol.187, pp.6804-6819, 2005.

D. Zannoni, The respiratory chains of pathogenic pseudomonads, Biochim Biophys Acta, vol.975, issue.3, pp.299-316, 1989.

L. Zeng and S. Jin, aph(3')-IIb, a gene encoding an aminoglycosidemodifying enzyme, is under the positive control of surrogate regulator HpaA, Antimicrob Agents Chemother, vol.47, issue.12, pp.3867-76, 2003.

H. I. Zgurskaya and H. Nikaido, Multidrug resistance mechanisms: drug efflux across two membranes, Mol Microbiol, vol.37, issue.2, pp.219-244, 2000.

G. G. Zhanel, J. A. Karlowsky, M. H. Saunders, R. J. Davidson, D. J. Hoban et al., Development of multipleantibiotic-resistant (Mar) mutants of Pseudomonas aeruginosa after serial exposure to fluoroquinolones, Antimicrob Agents Chemother, vol.39, issue.2, pp.489-95, 1995.

Q. Zhao, X. Z. Li, A. Mistry, R. Srikumar, L. Zhang et al.,

K. Poole, Influence of the TonB energy-coupling protein on efflux-mediated multidrug resistance in Pseudomonas aeruginosa, Antimicrob Agents Chemother, vol.42, issue.9, pp.2225-2256, 1998.

I. Ziha-zarifi, C. Llanes, T. Köhler, J. C. Pechere, and P. Plésiat, In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM, Antimicrob Agents Chemother, vol.43, issue.2, pp.287-91, 1999.